Add-on study of new biomarkers in Type 2 Diabetes Mellitus

PILOT TRIAL IN TYPE 2 DIABETES MELLITUS PATIENTS TO EXPLORE NEW FINGERPRINTS AND FUNCTIONAL MARKERS DURING START AND STOP OF REGULAR PHARMACOLOGICAL GLUCOSE LOWERING TREATMENT AS ADD-ON TO NEW COMPOUND PHASE 1 STUDIES

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20896

Enrollment

Registered

2013-06-03

Start date

2013-07-16

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus, wash-out and restart of metformin, explorative biomarkers of inflammation

Interventions

Non interventional study in which only blood and urine samples will be collected. (add-on procedures on top of new compound phase 1 studies, only for patients).

Eligibility

Inclusion criteria

Inclusion criteria: Diabetes Mellitus type 2 patients eligible to start wash-out as per criteria in new compound studies

Exclusion criteria

Exclusion criteria: N/A

Contacts

Public ContactR.G. Tiessen

PRA Early Development Services Stationsweg 163

tiessenrenger@praintl.com(31)-50-402 2386

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)